Skip to main content

Fludarabine Injection

Last Updated: February 2, 2023
Status: Current

Products Affected - Description
    • Fludarabine intravenous solution for injection, Fresenius Kabi, 25 mg/mL, 2 mL vial, 1 count, NDC 63323-0192-02
    • Fludarabine intravenous lyophilized powder for injection, Leucadia Pharmaceuticals, 50 mg, vial, 1 count, NDC 24201-0237-01
    • Fludarabine intravenous, Pfizer, 50 mg, vial, 1 count, NDC 61703-0344-18 - discontinued
    • Fludarabine intravenous solution for injection, Sagent, 25 mg/mL, 2 mL vial, 1 count, NDC 25021-0242-02
    • Fludarabine intravenous lyophilized powder for injection, Teva, 50 mg, vial, 1 count, NDC 45963-0309-55
    • Fludarabine intravenous solution for injection, Teva, 25 mg/mL, 2 mL vial, 1 count, NDC 45963-0621-51
Reason for the Shortage
    • Areva did not provide a reason for the shortage.
    • Fresenius Kabi has fludarabine injection on shortage due to increased demand.
    • Leucadia did not provide a reason for the shortage.
    • Pfizer discontinued fludarabine in August 2020. Their estimated market share was less than 1%.
    • Sagent has fludarabine on shortage due to manufacturing delays.
    • Teva did not provide a reason for the shortage.
Available Products
    • Fludarabine intravenous solution for injection, Areva, 25 mg/mL, 2 mL vial, 1 count, NDC 59923-0604-02

Estimated Resupply Dates

    • Areva has fludarabine 25 mg/mL 2 mL vials available for direct orders only.
    • Fresenius Kabi has fludarabine 25 mg/mL 2 mL vials on back order and the company estimates a release date of early-February 2023. Check wholesaler for availability.
    • Leucadia has fludarabine lyophilized powder 50 mg vials temporarily unavailable and the company cannot estimate a release date.
    • Sagent has fludarabine 25 mg/mL 2 mL vials on back order and the company estimates a release date of March 2023.
    • Teva has fludarabine 25 mg/mL 2 mL vials temporarily unavailable and the company cannot estimate a release date. The lyophilized powder 50 mg vials are on allocation.

Updated

Updated February 2, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created December 17, 2019 by Stephen Andrews, PharmD, BCPS, CPPS, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.